British regulators on Thursday said they have identified 30 cases of rare blood clot events after the use of the AstraZeneca COVID-19 vaccine, 25 more than the agency previously reported.
The Medicines and Healthcare products Regulatory Agency said it had received no such reports of clotting events following use of the vaccine made by BioNTech SE and Pfizer Inc.
The health officials said they still believe the benefits of the vaccine in the prevention of COVID-19 far outweigh any possible risk of blood clots.
Some countries are restricting use of the AstraZeneca vaccine while others have resumed inoculations, as investigations into reports of rare, and sometimes severe, blood clots continue.
On March 18, the UK medicines regulator said that there had been five cases of a rare brain blood clot among 11 million administered shots.
On Thursday, it put the count at 22 reports of cerebral venous sinus thrombosis, an extremely rare brain clotting ailment, and 8 reports of other clotting events associated with low blood platelets out of a total of 18.1 million doses given.
Follow us on:
Trump is considering Kevin Warsh for Treasury Secretary, with a future possibility of him becoming…
Hyundai has recalled 145,235 electrified vehicles in the US. due to potential loss of drive…
AGN president Rollas has stressed the need for actor licensing to ensure fair compensation and…
EU regulators has closed a four-year investigation into Apple's App Store rules after the complainant…
IPOB distanced itself from Simon Ekpa, calling him a “destructive agent” who infiltrated and destabilised…
Biden has condemned ICC's arrest warrants for Netanyahu and Gallant, calling them "outrageous" amid global…